97 related articles for article (PubMed ID: 11251179)
21. Differential display detects altered gene expression between cataractous and normal human lenses.
Kantorow M; Kays T; Horwitz J; Huang Q; Sun J; Piatigorsky J; Carper D
Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2344-54. PubMed ID: 9804143
[TBL] [Abstract][Full Text] [Related]
22. Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients.
Bjørbaek C; Vik TA; Echwald SM; Yang PY; Vestergaard H; Wang JP; Webb GC; Richmond K; Hansen T; Erikson RL
Diabetes; 1995 Jan; 44(1):90-7. PubMed ID: 7813820
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
[TBL] [Abstract][Full Text] [Related]
24. The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells.
Garcia-Haro L; Garcia-Gimeno MA; Neumann D; Beullens M; Bollen M; Sanz P
FASEB J; 2010 Dec; 24(12):5080-91. PubMed ID: 20724523
[TBL] [Abstract][Full Text] [Related]
25. Absence of PPP2R1B gene alterations in primary ovarian cancers.
Campbell IG; Manolitsas T
Oncogene; 1999 Nov; 18(46):6367-9. PubMed ID: 10597236
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer.
Xie W; Sun Y; Zeng Y; Hu L; Zhi J; Ling H; Zheng X; Ruan X; Gao M
Bioengineered; 2022 Jan; 13(1):190-205. PubMed ID: 34964699
[TBL] [Abstract][Full Text] [Related]
27. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
28. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.
Schmidt EE; Ichimura K; Goike HM; Moshref A; Liu L; Collins VP
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1170-83. PubMed ID: 10560660
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
[TBL] [Abstract][Full Text] [Related]
30. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
31. Colorectal carcinomas and PTEN/MMAC1 gene mutations.
Dicuonzo G; Angeletti S; Garcia-Foncillas J; Brugarolas A; Okrouzhnov Y; Santini D; Tonini G; Lorino G; De Cesaris M; Baldi A
Clin Cancer Res; 2001 Dec; 7(12):4049-53. PubMed ID: 11751500
[TBL] [Abstract][Full Text] [Related]
32. The selective inhibition of protein phosphatase-1 results in mitotic catastrophe and impaired tumor growth.
Winkler C; De Munter S; Van Dessel N; Lesage B; Heroes E; Boens S; Beullens M; Van Eynde A; Bollen M
J Cell Sci; 2015 Dec; 128(24):4526-37. PubMed ID: 26542020
[TBL] [Abstract][Full Text] [Related]
33. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers.
Yokomizo A; Tindall DJ; Drabkin H; Gemmill R; Franklin W; Yang P; Sugio K; Smith DI; Liu W
Oncogene; 1998 Jul; 17(4):475-9. PubMed ID: 9696041
[TBL] [Abstract][Full Text] [Related]
34. Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene.
Minaguchi T; Mori T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
Cancer Res; 1999 Dec; 59(24):6063-7. PubMed ID: 10626791
[TBL] [Abstract][Full Text] [Related]
35. Identification and allelic frequencies of novel single-nucleotide polymorphisms in the DUSP1 and BTG1 genes.
Suzuki C; Unoki M; Nakamura Y
J Hum Genet; 2001; 46(3):155-7. PubMed ID: 11310585
[TBL] [Abstract][Full Text] [Related]
36. Conserved synteny between the Fugu and human PTEN locus and the evolutionary conservation of vertebrate PTEN function.
Yu WP; Pallen CJ; Tay A; Jirik FR; Brenner S; Tan YH; Venkatesh B
Oncogene; 2001 Sep; 20(39):5554-61. PubMed ID: 11571655
[TBL] [Abstract][Full Text] [Related]
37. p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated expression of a naturally occurring Asp905Tyr variant of the glycogen-associated regulatory subunit of protein phosphatase-1 in L6 myotubes.
Rasmussen SK; Hansen L; Frevert EU; Cohen PT; Kahn BB; Pedersen O
Diabetologia; 2000 Jun; 43(6):718-22. PubMed ID: 10907117
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastases.
Hahn M; Wieland I; Koufaki ON; Görgens H; Sobottka SB; Schackert G; Schackert HK
Clin Cancer Res; 1999 Sep; 5(9):2431-7. PubMed ID: 10499615
[TBL] [Abstract][Full Text] [Related]
40. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
